Sunshine Biopharma, Inc. (SBFM)

USD 2.75

(0.37%)

Total Liabilities Summary of Sunshine Biopharma, Inc.

  • Sunshine Biopharma, Inc.'s latest annual total liabilities in 2023 was 6.13 Million USD , down -19.39% from previous year.
  • Sunshine Biopharma, Inc.'s latest quarterly total liabilities in 2024 Q2 was 5.81 Million USD , down -17.91% from previous quarter.
  • Sunshine Biopharma, Inc. reported annual total liabilities of 7.61 Million USD in 2022, up 282.49% from previous year.
  • Sunshine Biopharma, Inc. reported annual total liabilities of 1.99 Million USD in 2021, down -0.45% from previous year.
  • Sunshine Biopharma, Inc. reported quarterly total liabilities of 5.81 Million USD for 2024 Q2, down -17.91% from previous quarter.
  • Sunshine Biopharma, Inc. reported quarterly total liabilities of 7.56 Million USD for 2023 Q1, down -0.71% from previous quarter.

Annual Total Liabilities Chart of Sunshine Biopharma, Inc. (2023 - 2007)

Historical Annual Total Liabilities of Sunshine Biopharma, Inc. (2023 - 2007)

Year Total Liabilities Total Liabilities Growth
2023 6.13 Million USD -19.39%
2022 7.61 Million USD 282.49%
2021 1.99 Million USD -0.45%
2020 2 Million USD 139.98%
2019 833.52 Thousand USD -30.67%
2018 1.2 Million USD 44.71%
2017 830.84 Thousand USD 203.11%
2016 274.1 Thousand USD -78.42%
2015 1.27 Million USD 139.23%
2014 531 Thousand USD 1263.29%
2013 38.95 Thousand USD -39.49%
2012 64.36 Thousand USD 1774.4%
2011 3434.00 USD -69.89%
2010 11.4 Thousand USD -20.33%
2009 14.31 Thousand USD -37.05%
2008 22.73 Thousand USD 1415.93%
2007 1500.00 USD 0.0%

Peer Total Liabilities Comparison of Sunshine Biopharma, Inc.

Name Total Liabilities Total Liabilities Difference
Theratechnologies Inc. 98.63 Million USD 93.776%
Harrow Health, Inc. 241.75 Million USD 97.46%
Dynavax Technologies Corporation 375.02 Million USD 98.363%
Biofrontera Inc. 23.13 Million USD 73.466%
Cronos Group Inc. 43.73 Million USD 85.962%
Sonoma Pharmaceuticals, Inc. 8.75 Million USD 29.881%
Ironwood Pharmaceuticals, Inc. 817.36 Million USD 99.249%
Kala Pharmaceuticals, Inc. 48.44 Million USD 87.327%
RedHill Biopharma Ltd. 20.97 Million USD 70.733%
Cumberland Pharmaceuticals Inc. 52.51 Million USD 88.309%
Radius Health, Inc. 804.29 Million USD 99.237%
Universe Pharmaceuticals INC 13.75 Million USD 55.362%
DURECT Corporation 30.4 Million USD 79.808%
ProPhase Labs, Inc. 42.54 Million USD 85.569%
Safety Shot Inc 3.89 Million USD -57.747%
Phibro Animal Health Corporation 725.54 Million USD 99.154%
China SXT Pharmaceuticals, Inc. 9.19 Million USD 33.241%
Alvotech 1.88 Billion USD 99.674%
Assertio Holdings, Inc. 148.41 Million USD 95.863%
Supernus Pharmaceuticals, Inc. 487.46 Million USD 98.74%
Rockwell Medical, Inc. 30.88 Million USD 80.119%
Procaps Group S.A. 462.06 Million USD 98.671%
Intra-Cellular Therapies, Inc. 136.87 Million USD 95.514%
SCYNEXIS, Inc. 55.45 Million USD 88.928%
Aytu BioPharma, Inc. 90.37 Million USD 93.207%
Viatris Inc. 27.21 Billion USD 99.977%
OptiNose, Inc. 194.33 Million USD 96.841%
SIGA Technologies, Inc. 57.97 Million USD 89.41%
Tilray Brands, Inc. 892.11 Million USD 99.312%
PetIQ, Inc. 645.22 Million USD 99.048%
Sunshine Biopharma, Inc. 6.13 Million USD 0.0%
Neurocrine Biosciences, Inc. 1.01 Billion USD 99.398%
Guardion Health Sciences, Inc. 3.77 Million USD -62.762%
Alimera Sciences, Inc. 107.35 Million USD 94.281%
Collegium Pharmaceutical, Inc. 947.87 Million USD 99.352%
Silver Spike Investment Corp. 3 Million USD -103.985%
Shuttle Pharmaceuticals Holdings, Inc. 1.89 Million USD -223.825%
Organogenesis Holdings Inc. 181.36 Million USD 96.615%
Journey Medical Corporation 56.49 Million USD 89.133%
Petros Pharmaceuticals, Inc. 21.31 Million USD 71.197%
Alpha Teknova, Inc. 38.55 Million USD 84.074%
Clever Leaves Holdings Inc. 7.02 Million USD 12.616%
Lifecore Biomedical, Inc. 219.8 Million USD 97.207%
PainReform Ltd. 2.69 Million USD -128.153%
Cosmos Health Inc. 30.25 Million USD 79.705%
Avadel Pharmaceuticals plc 173.38 Million USD 96.459%
TherapeuticsMD, Inc. 14.02 Million USD 56.215%
Embecta Corp. 2.03 Billion USD 99.698%
Regencell Bioscience Holdings Limited 219.51 Thousand USD -2696.931%
Talphera, Inc. 6.29 Million USD 2.391%
Pacira BioSciences, Inc. 704.25 Million USD 99.128%
Incannex Healthcare Limited 5.83 Million USD -5.31%
Cyclo Therapeutics, Inc. 8.49 Million USD 27.689%
Shineco, Inc. 47.6 Million USD 87.102%
Procaps Group, S.A. 462.06 Million USD 98.671%
ANI Pharmaceuticals, Inc. 471.67 Million USD 98.698%
Aquestive Therapeutics, Inc. 163.9 Million USD 96.254%
Lantheus Holdings, Inc. 835.25 Million USD 99.265%
Alvotech 1.88 Billion USD 99.674%
Hempacco Co., Inc. 18.82 Million USD 67.381%
Eagle Pharmaceuticals, Inc. 172.6 Million USD 96.443%
Bright Green Corporation 6.43 Million USD 4.636%
Esperion Therapeutics, Inc. 660.79 Million USD 99.071%
Kamada Ltd. 109.96 Million USD 94.417%
Indivior PLC 1.95 Billion USD 99.685%
Evoke Pharma, Inc. 9.64 Million USD 36.365%
Flora Growth Corp. 17.22 Million USD 64.35%
Cyclo Therapeutics, Inc. 8.49 Million USD 27.689%
Evolus, Inc. 209.68 Million USD 97.072%
HUTCHMED (China) Limited 536.38 Million USD 98.855%
Amphastar Pharmaceuticals, Inc. 873.49 Million USD 99.297%
Akanda Corp. 12.66 Million USD 51.538%